Lintao Jia

4.6k total citations · 2 hit papers
88 papers, 3.5k citations indexed

About

Lintao Jia is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lintao Jia has authored 88 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 36 papers in Cancer Research and 19 papers in Oncology. Recurrent topics in Lintao Jia's work include Cancer-related molecular mechanisms research (21 papers), MicroRNA in disease regulation (16 papers) and RNA modifications and cancer (15 papers). Lintao Jia is often cited by papers focused on Cancer-related molecular mechanisms research (21 papers), MicroRNA in disease regulation (16 papers) and RNA modifications and cancer (15 papers). Lintao Jia collaborates with scholars based in China, United States and Russia. Lintao Jia's co-authors include Angang Yang, Yanlu Xiong, Yong Han, Xiaofei Li, Yangbo Feng, Tianyun Qiao, Lei Wang, Rui Zhang, Libo Yao and Jing Zhao and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Lintao Jia

83 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy

2018 480 citations Yanlu Xiong, Lintao Jia et al. profile →
Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD

2024 60 citations Yang Long, Kunwei Niu et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Lintao Jia

Since Specialization

Citations

This map shows the geographic impact of Lintao Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lintao Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lintao Jia more than expected).

Fields of papers citing papers by Lintao Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lintao Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lintao Jia. The network helps show where Lintao Jia may publish in the future.

Co-authorship network of co-authors of Lintao Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Lintao Jia. A scholar is included among the top collaborators of Lintao Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lintao Jia. Lintao Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting endothelial MYC using siRNA or miR-218 nanoparticles sensitizes chemo- and immuno-therapies by recapitulating the Notch activation-induced tumor vessel normalization 2025 ·Theranostics ·Xianchun Yan, Ziyan Yang, Xiu‐Li Cao, Liang Liang, Yanyan Duan, (unknown), (unknown), (unknown), (unknown), Lintao Jia, Jiaxing Sun, Hua Han	0
2	Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD breakdown → 2024 ·Journal of Hepatology ·Yang Long, Kunwei Niu, Jianlin Wang, (unknown), Rui Jiang, Lu Liu, Wenjie Song, Xudan Wang, Xuan Zhang, Ruohan Zhang, (unknown), (unknown), Lintao Jia, Kaishan Tao	60
3	Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma 2024 ·Cell Reports ·Huina Wang, Xiuli Yi, (unknown), Yuqi Yang, (unknown), Hao Wang, Jianru Chen, Baolu Zhang, Sen Guo, Lili Wu, Juan Du, Yuhan Chen, (unknown), Tianwen Gao, Rui Zhang, Huijie Bian, Lintao Jia, Chunying Li, Weinan Guo	12
4	Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma 2022 ·Journal of Translational Medicine ·Guoyin Li, Zewen Song, Changjing Wu, Xiaoyan Li, Liping Zhao, (unknown), (unknown), Meiqing Sun, Jin Zhao, Huina Zhang, Lintao Jia, Shengqing Li, Lei Wang	13
5	The XBP1‒MARCH5‒MFN2 Axis Confers Endoplasmic Reticulum Stress Resistance by Coordinating Mitochondrial Fission and Mitophagy in Melanoma 2021 ·Journal of Investigative Dermatology ·Huina Wang, Xiuli Yi, Sen Guo, Sijia Wang, Jinyuan Ma, Tao Zhao, Qiong Shi, Yangzi Tian, (unknown), Lintao Jia, Tianwen Gao, Chunying Li, Weinan Guo	28
6	MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma 2018 ·Cancer Letters ·Xiang Zhang, Xiao Zhang, Ting Wang, Lei Wang, Zhijun Tan, Wei Wei, Bo Yan, Jing Zhao, Kaichun Wu, Angang Yang, Rui Zhang, Lintao Jia	47
7	Nkx2-2as Suppression Contributes to the Pathogenesis of Sonic Hedgehog Medulloblastoma 2017 ·Cancer Research ·Yimeng Zhang, Ting Wang, Shan Wang, Yanlu Xiong, Rui Zhang, Xiang Zhang, Jing Zhao, Angang Yang, Lei Wang, Lintao Jia	34
8	Targeted inhibition of hantavirus replication and intracranial pathogenesis by a chimeric protein-delivered siRNA 2017 ·Antiviral Research ·Jie Yang, (unknown), Tingting Wang, (unknown), Junxia Wei, Lintao Jia, Angang Yang	5
9	Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R 2014 ·BMC Cancer ·Xingming Ye, Huayu Zhu, Wendong Bai, Ting Wang, Lei Wang, Ying Chen, Angang Yang, Lintao Jia	98
10	Post-Transcriptional Up-Regulation of PDGF-C by HuR in Advanced and Stressed Breast Cancer 2014 ·International Journal of Molecular Sciences ·(unknown), (unknown), Guodong Yang, Tao Wang, Renli Li, Lintao Jia, Rui Dong	14
11	Potent killing of HBV-related hepatocellular carcinoma by a chimeric protein of anti-HBsAg single-chain antibody and truncated Bid 2013 ·Biomaterials ·Bo Yan, Qing Ouyang, (unknown), Feng Cao, Tao Wang, Xiaofei Jia, Yan–Ling Meng, Shuai Jiang, Jiayun Liu, Rui Chen, Lintao Jia, Rui Zhang, Weihong Wen, Boquan Jin, Siyi Chen, Jing Zhao, Angang Yang	8
12	RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling 2012 ·Neuro-Oncology ·Bei Liu, Liang Wang, Liangliang Shen, Mingzhi Shen, Xiaodong Guo, (unknown), Qinchuan Liang, Chao Wang, Jun Zheng, Yi Li, Lintao Jia, Hua Zhang, Guodong Gao	26
13	The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells 2011 ·Biomaterials ·Jun Ren, Yan–Ling Meng, Bin Hu, Lintao Jia, Rui Zhang, Yan‐Ming Xu, (unknown), Yingqi Zhang, Boquan Jin, Si‐Yi Chen, Tao Wang, Angang Yang	11
14	Deregulated miR‐155 promotes Fas‐mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase‐3 2011 ·The Journal of Pathology ·Hai‐Qiang Wang, Yu Xiaodong, Zhi‐Heng Liu, Xin Cheng, Dino Samartzis, Lintao Jia, Shengxi Wu, Jing Huang, Jing Chen, Zhuojing Luo	188
15	Inhibition of Human Breast Cancer Cell Invasion by siRNA Against Urokinase-Type Plasminogen Activator 2010 ·Cancer Investigation ·Hongyan Huang, Zefei Jiang, Qingxia Li, Jiayun Liu, Tao Wang, Rui Zhang, Jing Zhao, Yan‐Ming Xu, (unknown), Yong Zhang, Lintao Jia, Angang Yang	19
16	Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu 2009 ·Cancer Letters ·Xinling Ren, Yan‐Ming Xu, (unknown), Haijing Fu, Changgui Wu, Ying Zhao, Zhikui Li, Jiän Zhang, Shengqing Li, Weiqiang Chen, Tao Wang, Rui Zhang, Lihong Zhang, Guisheng Qian, Si–Yi Chen, Lintao Jia, Angang Yang	12
17	Recombinant Immunoproapoptotic Proteins with Furin Site Can Translocate and Kill HER2-Positive Cancer Cells 2007 ·Cancer Research ·Tao Wang, Jing Zhao, Jun Ren, Li Zhang, Weihong Wen, Rui Zhang, Weiwei Qin, Lintao Jia, Libo Yao, Yingqi Zhang, Si‐Yi Chen, Angang Yang	45
18	Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery 2007 ·Hepatology ·Weihong Wen, Jiayun Liu, Weijun Qin, Jing Zhao, Tao Wang, Lintao Jia, Yan–Ling Meng, Hui Gao, (unknown), Boquan Jin, Libo Yao, (unknown), Angang Yang	41
19	A Caspase-6 and Anti-Human Epidermal Growth Factor Receptor-2 (HER2) Antibody Chimeric Molecule Suppresses the Growth of HER2-Overexpressing Tumors 2004 ·The Journal of Immunology ·Yan‐Ming Xu, Lifeng Wang, Lintao Jia, Xiuchun Qiu, Jing Zhao, (unknown), Rui Zhang, Feng Zhu, Chengji Wang, Boquan Jin, Si–Yi Chen, Angang Yang	34
20	Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3. 2003 ·PubMed ·Lintao Jia, (unknown), (unknown), Jing Zhao, Yan‐Ming Xu, (unknown), Ming Jin, (unknown), (unknown), (unknown), Si-Yi Chen, (unknown)	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact